John Evenden
6Patents
4h-index
8Co-inventors
42Inventor score
Filing activity: Jan 4, 1995 → Jul 9, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5962514A | Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist | Human Necessities | 9 | Expired |
| US6184219A | Composition and methods employing it for the treatment of 5-HT-mediated disorders | Human Necessities | 4 | Expired |
| US6172105A | Composition and methods employing it for the treatment of 5-HT-mediated disorders | Human Necessities | 4 | Expired |
| US5616610A | (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzo pyrans | Chemistry; Metallurgy | 4 | Expired |
| US6184218A | Composition and methods employing it for the treatment of 5-HT-mediated disorders | Human Necessities | 1 | Expired |
| US6169098A | Composition and methods employing it for the treatment of 5-HT-mediated disorders | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.